Sinco Pharmaceuticals Holdings Limited The board of directors of Sinco Pharmaceuticals Holdings Limited hereby announces that Mr. Li Kin Wai has resigned as the joint company secretaries of the Company and an authorised representative of the Company (the "Authorised Representative") under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Stock Exchange") with effect from 26 March 2024. Following Mr. Li's resignation, Ms. Peng Yunlu, the other Joint Company Secretary will remain in office as the sole company secretary of the Company. Ms. Peng has been admitted as a member of The Hong Kong Chartered Governance Institute and therefore satisfies the qualification of a company secretary as required under Rule 3.28 and 8.17 of the Listing Rules.

Ms. Peng has also been appointed as the Authorised Representative with effect from 26 March 2024 in replacement of Mr. Li. Ms. Peng is primarily responsible for coordinating the meetings of the Board and the shareholders, handling corporate disclosure pursuant to the Listing Rules as well as attending to corporate governance affairs. Ms. Peng joined the Group and has been working for Sichuan Sinco Pharmaceuticals Co.

Ltd. ("Sichuan Sinco") since 2013. She has held important positions in Quality Management Department, Purchasing Department, Capital Department and Accounting Department in Sichuan Sinco during the period. Ms. Peng is a Chartered Secretary and a Chartered Governance Professional as well as an associate of both The Hong Kong Chartered Governance Institute and The Chartered Governance Institute.

Ms. Peng holds a master's degree in international business from University of Birmingham and a master of Corporate Governance degree from the Hong Kong Metropolitan University. The board of directors announced that Mr. Huang Zhijian ("Mr. Huang") has been appointed as an executive director of the Company ("Executive Director"), with effect from 26 March 2024, in accordance of article 16.2 as set out in Memorandum and Articles of Association of the Company, until the next annual general meeting of the Company after his appointment and shall then be eligible for re-election at that meeting. Mr. Huang, aged 31, joined our Group in January 2018 as the assistant product manager of Sichuan Sinco.

Mr. Huang was appointed as the general manager of Sichuan Sinco and Qingdao Yusheng Hengying Trading Co. Ltd. ("Qingdao Yusheng") in November 2022 and December 2022, respectively, mainly responsible for overall business operation and management. Mr. Huang is also the director of Sichuan Sinco, Qingdao Yusheng, Sinco Shanghai Trading Co.

Ltd., Haikou Sinco Biological Medical Technology Co. Ltd., and Sinco (Hainan) Investment Development Co. Ltd. From June 2018 to November 2022, he was the sales manager of Sichuan Sinco.

Mr. Huang obtained a master's degree in Business Administration from ESC PAU Business School in 2021 and graduated from Haikou University of Economics in 2020 with a bachelor's degree in financial management.